Case File №
#VI-2026-0519
Dragon Pharma
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
39 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Tesamorelin | X Unrated | 1 | 5.8 | 5.8 | 5.8 | 24 Jul 2025 |
| Anadrol (Oxymetholone) | X N/A | 1 | 4.7 | 4.7 | 4.7 | 3 Jul 2025 |
| Blend 300 (TRA/Mast P/Test P) | X N/A | 1 | 4.4 | 4.4 | 4.4 | 7 May 2025 |
| Boldenone Undecylenate (EQ) Raw | X N/A | 1 | 5.3 | 5.3 | 5.3 | 13 Feb 2025 |
| BPC157 5mg + TB500 5mg Blend | X N/A | 1 | 8.7 | 8.7 | 8.7 | 24 Apr 2025 |
| Cerebrolysin | X N/A | 1 | 5.5 | 5.5 | 5.5 | 16 Mar 2025 |
| Deca (Nandrolone Decanoate) | X N/A | 1 | 5.7 | 5.7 | 5.7 | 20 Jun 2025 |
| Dianabol | X N/A | 1 | 7.0 | 7.0 | 7.0 | 13 Feb 2025 |
| Drostanolone Enanthate (Mast E) Raw | X N/A | 1 | 6.6 | 6.6 | 6.6 | 7 May 2025 |
| Enclomiphene | X N/A | 1 | 4.0 | 3.7 | 3.7 | 2 Apr 2025 |
| Epithalon | X N/A | 1 | 6.3 | 6.3 | 6.3 | 9 Jun 2025 |
| EPO | X N/A | 1 | 7.6 | 7.6 | 7.6 | 21 May 2025 |
| Equipoise (Boldenone Undecylenate) | X N/A | 1 | 6.5 | 6.5 | 6.5 | 13 Feb 2025 |
| GHRP-2 Acetate | X N/A | 1 | 4.0 | 3.9 | 3.9 | 6 May 2025 |
| Hyaluronic acid | X N/A | 1 | 4.0 | 3.0 | 3.0 | 3 Jun 2025 |
| Ivermectin | X N/A | 1 | 5.6 | 5.6 | 5.6 | 17 Dec 2024 |
| KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | X N/A | 1 | 5.6 | 5.6 | 5.6 | 17 Dec 2024 |
| KPV Oral | X N/A | 1 | 4.0 | 3.9 | 3.9 | 27 Feb 2025 |
| L-Carnitine 500mg | X N/A | 1 | 4.0 | 3.3 | 3.3 | 27 Feb 2025 |
| LGD-4033 (Ligandrol) | X N/A | 1 | 4.8 | 4.8 | 4.8 | 2 Apr 2025 |
| MGF | X N/A | 1 | 7.8 | 7.8 | 7.8 | 11 Jun 2025 |
| MOTS-C | X N/A | 1 | 5.9 | 5.9 | 5.9 | 27 Feb 2025 |
| MT-1 | X N/A | 1 | 7.1 | 7.1 | 7.1 | 3 Jun 2025 |
| NA Selank Amidate | X N/A | 1 | 7.9 | 7.9 | 7.9 | 3 Jun 2025 |
| NA Semax Amidate | X N/A | 1 | 5.7 | 5.7 | 5.7 | 14 Jan 2025 |
| NAD+ | X N/A | 1 | 6.3 | 6.3 | 6.3 | 3 Jun 2025 |
| Ovagen | X N/A | 1 | 4.0 | 3.3 | 3.3 | 27 Feb 2025 |
| Oxytocin Acetate | X N/A | 1 | 7.0 | 7.0 | 7.0 | 11 Jun 2025 |
| P2NP (1-phenyl-2-nitropropene) CAS 705-60-2 | X N/A | 1 | 7.6 | 7.6 | 7.6 | 25 Apr 2025 |
| Pancragen | X N/A | 1 | 4.7 | 4.7 | 4.7 | 7 May 2025 |
| Phenethyl bromide (2-bromoethylbenzene) CAS 103-63-9 | X N/A | 1 | 4.9 | 4.9 | 4.9 | 27 Feb 2025 |
| Retatrutide 30mg Pen Kit | X N/A | 1 | 5.4 | 5.4 | 5.4 | 27 Feb 2025 |
| RIPEX 225 (TRA/Mast P/Test P) | X N/A | 1 | 6.2 | 6.2 | 6.2 | 25 Apr 2025 |
| Selank | X N/A | 1 | 4.6 | 4.6 | 4.6 | 6 May 2025 |
| Semax | X N/A | 1 | 5.4 | 5.4 | 5.4 | 25 Apr 2025 |
| Telmisartan | X N/A | 1 | 4.2 | 4.2 | 4.2 | 6 May 2025 |
| Test Suspension | X N/A | 1 | 4.8 | 4.8 | 4.8 | 28 Mar 2025 |
| Testosterone Propionate Raw | X N/A | 1 | 6.0 | 6.0 | 6.0 | 27 Feb 2025 |
| Vilon | X N/A | 1 | 6.9 | 6.9 | 6.9 | 13 Jun 2025 |
Exhibit II
Evidence Log
39 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 25 May 2026 | Anadrol (Oxymetholone) | 4.0 C | 25mg | 31.0mg | +24.0% | 99.14% | aluj3d | Lab A | Public |
| 25 May 2026 | Vilon | 8.3 A | 30mg | 29.7mg | -1.0% | 95.64% | k5316m | Lab D | Community |
| 24 May 2026 | KPV Oral | 4.3 C | 20mg | 18.0mg | -10.2% | 99.02% | niavaq | Lab A | Public |
| 24 May 2026 | MGF | 9.7 A | 20mg | 18.2mg | -8.9% | 95.34% | kw33fl | Lab F | Public |
| 24 May 2026 | L-Carnitine 500mg | 4.7 C | 250mg/ml | 278.4mg/ml | +11.4% | 96.53% | 35gxvf | Lab C | Public |
| 24 May 2026 | RIPEX 225 (TRA/Mast P/Test P) | 5.4 B | 100mg/ml | 93.5mg/ml | -6.5% | 97.07% | 58wo7l | Lab F | Community |
| 24 May 2026 | Selank | 4.0 C | 50mg | 51.5mg | +3.0% | 95.63% | wkqcub | Lab C | Community |
| 24 May 2026 | Blend 300 (TRA/Mast P/Test P) | 4.9 C | 200mg/ml | 236.7mg/ml | +18.3% | 99.97% | 8zaw9s | Lab C | Community |
| 24 May 2026 | NAD+ | 7.5 A | 10mg | 9.6mg | -4.3% | 98.50% | bvc3g9 | Lab C | Public |
| 23 May 2026 | Ovagen | 4.7 C | 10mg | 12.4mg | +24.0% | 98.32% | oaolpp | Lab F | Public |
| 21 May 2026 | Enclomiphene | 4.9 C | 20mg | 17.1mg | -14.3% | 98.83% | xen4hb | Lab F | Public |
| 21 May 2026 | Ivermectin | 5.9 B | 100mg | 119.1mg | +19.1% | 98.22% | dpmjkl | Lab F | Community |
| 21 May 2026 | MT-1 | 9.6 A | 50mg | 53.3mg | +6.7% | 96.33% | e7fp0i | Lab E | Public |
| 21 May 2026 | NA Selank Amidate | 9.0 A | 30mg | 31.0mg | +3.5% | 95.22% | b8nkkv | Lab C | Community |
| 21 May 2026 | Semax | 4.3 C | 10mg | 11.1mg | +11.3% | 95.75% | 6kdw2h | Lab B | Community |
| 20 May 2026 | Hyaluronic acid | 5.0 B | 20mg | 24.4mg | +21.9% | 96.04% | 71f9jl | Lab F | Public |
| 20 May 2026 | Pancragen | 4.4 C | 50mg | 57.1mg | +14.2% | 95.63% | k4hekc | Lab A | Public |
| 17 May 2026 | Epithalon | 5.9 B | 20mg | 21.3mg | +6.4% | 95.68% | fbxrqt | Lab B | Public |
| 29 Jan 2026 | EPO | 5.2 B | 20mg | 23.2mg | +16.0% | 97.14% | w8zrh0 | Lab B | Public |
| 29 Jan 2026 | GHRP-2 Acetate | 4.3 C | 20mg | 19.7mg | -1.7% | 98.17% | cxvl2y | Lab A | Public |
| 26 Jan 2026 | Retatrutide 30mg Pen Kit | 6.9 A | 2mg | 2.1mg | +7.2% | 95.79% | x4bksc | Lab B | Community |
| 26 Jan 2026 | Test Suspension | 4.7 C | 250mg/ml | 291.1mg/ml | +16.4% | 95.05% | bmv6qy | Lab B | Community |
| 9 Jan 2026 | Boldenone Undecylenate (EQ) Raw | 5.4 B | 10g | 10.9g | +8.9% | 95.06% | w7wcr4 | Lab A | Community |
| 9 Jan 2026 | Phenethyl bromide (2-bromoethylbenzene) CAS 103-63-9 | 5.5 B | 10g | 12.5g | +25.0% | 98.64% | k9anxq | Lab E | Public |
| 7 Jan 2026 | Cerebrolysin | 4.0 C | 15mg | 17.0mg | +13.1% | 95.23% | ao359t | Lab B | Public |
| 6 Jan 2026 | LGD-4033 (Ligandrol) | 6.5 A | 50mg | 44.3mg | -11.4% | 98.20% | jcxrnl | Lab D | Public |
| 6 Jan 2026 | MOTS-C | 8.0 A | 2mg | 2.0mg | -1.6% | 98.79% | 55cmf6 | Lab G | Public |
| 29 Dec 2025 | Dianabol | 7.5 A | 10mg | 12.0mg | +20.3% | 95.04% | 3foplm | Lab E | Public |
| 29 Dec 2025 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 6.3 A | 2mg | 2.0mg | +1.2% | 95.92% | jn7c5g | Lab A | Public |
| 12 Dec 2025 | Deca (Nandrolone Decanoate) | 4.0 C | 200mg/ml | 172.3mg/ml | -13.8% | 96.14% | cg2mfw | Lab D | Public |
| 12 Dec 2025 | Equipoise (Boldenone Undecylenate) | 6.6 A | 250mg/ml | 271.3mg/ml | +8.5% | 97.28% | vl42xu | Lab F | Public |
| 23 Nov 2025 | Drostanolone Enanthate (Mast E) Raw | 5.8 B | 100g | 118.9g | +18.9% | 95.65% | nbvryy | Lab B | Public |
| 17 Nov 2025 | Telmisartan | 4.0 C | 25mg | 26.4mg | +5.8% | 98.75% | 7cd9z7 | Lab G | Community |
| 17 Oct 2025 | NA Semax Amidate | 4.4 C | 2mg | 2.4mg | +21.7% | 98.48% | u1zkfk | Lab B | Public |
| 17 Oct 2025 | Testosterone Propionate Raw | 8.6 A | 500g | 608.8g | +21.8% | 96.79% | 66rlya | Lab A | Public |
| 9 Oct 2025 | BPC157 5mg + TB500 5mg Blend | 9.1 A | 2mg | 2.5mg | +23.5% | 98.33% | ijex5w | Lab D | Public |
| 9 Oct 2025 | Oxytocin Acetate | 7.7 A | 50mg | 51.8mg | +3.5% | 99.65% | fajs4g | Lab F | Community |
| 9 Oct 2025 | P2NP (1-phenyl-2-nitropropene) CAS 705-60-2 | 6.0 A | 5g | 5.3g | +7.0% | 99.65% | izrxl2 | Lab B | Community |
| 24 Jul 2025 | Tesamorelin | 5.8 C | 5mg | 4.7mg | -6.0% | 99.06% | (no batch ID) | Lab A | Public |
— END OF EVIDENCE LOG —